When it comes to weight loss drugs, Ozempic has become a phenomenon. With nearly $14 billion in sales in 2023, it shows no ...

Ozempic is under clinical development by Novo Nordisk and currently in Phase III for Peripheral Arterial Disease (PAD)/ Peripheral Vascular Disease (PVD).

Following rapid (and pricey) expansion efforts from Novo and Lilly, plus recent shortage updates at the FDA, “positive ...

As weight-loss drugs have exploded in popularity this past year, part of the craze has been members of the public wondering which celebrities are on Ozempic.

In recent developments, health officials in Europe have launched an investigation into the popular weight loss drug Ozempic, ...

The drugs that Novo Nordisk and Eli Lilly market for the treatment of obesity ... agonist that the Food and Drug Administration (FDA) approved as Ozempic and Rybelsus to treat diabetes and later as ...

For Floridians, 2024 was a year of weight loss and emerging revelations about anti-obesity medications.

Ozempic has become a popular wonder drug among many Hollywood celebrities, who turned to the diabetes medication to lose ...

Since the start of 2020, Eli Lilly’s (NYSE: LLY) e estimate Rivian’s stock price to be $140.00 per share. Our estimated stock ...

Learn how the power of dividend growth investing and how commitment and a long-term mindset can help you reach your financial ...

From weight-loss drugs to nonopioid pain killers to AI, here are some important -- and positive -- trends in health care.

The Malaysian Pharmacists Society (MPS) has reportedly raised concerns over a shortage of Ozempic, a diabetes medication, due ...